Superworth

Enovis CORP price to book ratio ENOV

Market value divided by the book value of the company's net assets, since 2011.

Today, Oct 23, 2026
0.8×
10-year median
0.8×
Against its 10-year history
58th
percentile: 0 is its lowest day, 100 its highest
10-year range
0.3× to 1.1×
Peer median
3.4×

Enovis CORP's price to book ratio is 0.8× as of Oct 23, 2026.

That is above its ten-year median of 0.8×, close to the middle of its last ten years.

Over that time it ranged from 0.3× in Apr 2020 to 1.1× in Jul 2026.

The median for 10 medical instruments and supplies stocks of a similar size is 3.4×.

Price to book ratio over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far0.8×0.6×1.1×
20250.8×0.6×0.9×
20240.7×0.7×1.0×
20230.9×0.7×1.0×
20220.9×0.6×0.9×
20210.9×0.7×1.0×
20200.8×0.3×0.9×
20190.8×0.4×0.8×
20180.4×0.4×0.9×
20170.8×0.8×1.0×
20160.9×0.5×0.9×
20150.5×0.5×1.2×
20141.1×1.0×1.7×
20131.6×1.1×1.6×
20121.1×0.7×9.1×
20112.9×2.0×3.2×

Against its peers

Companies in Medical - Instruments & Supplies nearest Enovis CORP's size, closest first, today.

CompanyPrice to book ratio
ENOVEnovis CORP0.8×
BVSBioventus5.5×
CDRECadre3.7×
STAAStaar Surgical3.1×
IRMDIradimed10.8×
EYENational Vision1.6×
LMATLemaitre Vascular4.6×
INSPInspire Medical Systems2.5×
MOVMovado1.4×
UFPTUFP Technologies5.0×
MDXGMimedx2.6×
Peer median3.4×

What the price to book ratio tells you

Market value divided by the accounting value of the company's net assets. Below 1 means the market values the business at less than what it owns on paper.

Book value misses brands, software and people, so asset-light companies always look expensive on it. Most useful for banks and industrials.

More on Enovis CORP

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.